Xiao-Jian Zhou
Idenix Pharmaceuticals
Inc, One Kendall Square
Building 1400
USA
Name/email consistency: high
- Population pharmacokinetics of telbivudine and determination of dose adjustment for patients with renal impairment. Zhou, X.J., Ke, J., Sallas, W.M., Farrell, C., Mayers, D.L., Pentikis, H.S. J. Clin. Pharmacol (2009)
- Pharmacokinetics of telbivudine in subjects with various degrees of renal impairment. Zhou, X.J., Swan, S., Smith, W.B., Marbury, T.C., Dubuc-Patrick, G., Chao, G.C., Brown, N.A. Antimicrob. Agents Chemother. (2007)
- Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications. Zhou, X.J., Lim, S.G., Lloyd, D.M., Chao, G.C., Brown, N.A., Lai, C.L. Antimicrob. Agents Chemother. (2006)
- Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment. Zhou, X.J., Marbury, T.C., Alcorn, H.W., Smith, W.B., Dubuc Patrick, G., Chao, G.C., Brown, N.A. Antimicrob. Agents Chemother. (2006)
- Pharmacokinetics of telbivudine in healthy subjects and absence of drug interaction with lamivudine or adefovir dipivoxil. Zhou, X.J., Fielman, B.A., Lloyd, D.M., Chao, G.C., Brown, N.A. Antimicrob. Agents Chemother. (2006)
